Allscripts Healthcare Solutions - MDRX Stock Forecast, Price & News

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allscripts Healthcare Solutions in the last year. There are currently 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" MDRX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDRX, but not buy additional shares or sell existing shares.
View MDRX analyst ratings or view top-rated stocks.

6 brokers have issued twelve-month price targets for Allscripts Healthcare Solutions' stock. Their MDRX share price forecasts range from $17.00 to $26.00. On average, they expect the company's share price to reach $22.00 in the next year. This suggests a possible upside of 32.0% from the stock's current price.
View analysts price targets for MDRX or view top-rated stocks among Wall Street analysts.

Allscripts Healthcare Solutions' stock was trading at $18.45 at the beginning of the year. Since then, MDRX stock has decreased by 9.6% and is now trading at $16.67.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our MDRX earnings forecast.

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) announced its earnings results on Thursday, August, 4th. The software maker reported $0.18 earnings per share for the quarter, topping analysts' consensus estimates of $0.15 by $0.03. The software maker had revenue of $150.90 million for the quarter, compared to the consensus estimate of $148.58 million. Allscripts Healthcare Solutions had a net margin of 5.90% and a trailing twelve-month return on equity of 10.62%. The business's revenue for the quarter was up 6.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.17 earnings per share.

Allscripts Healthcare Solutions declared that its board has authorized a stock repurchase program on Wednesday, May 26th 2021, which authorizes the company to repurchase $350,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 14% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company's management believes its shares are undervalued.

796 employees have rated Allscripts Healthcare Solutions Chief Executive Officer Paul Black on Glassdoor.com. Paul Black has an approval rating of 65% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Allscripts Healthcare Solutions investors own include Advanced Micro Devices (AMD), Netflix (NFLX), Energy Transfer (ET), CVS Health (CVS), Ford Motor (F), Himax Technologies (HIMX), Intel (INTC), OPKO Health (OPK), Tesla (TSLA) and Activision Blizzard (ATVI).

Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."

Allscripts Healthcare Solutions' stock is owned by a variety of institutional and retail investors. Top institutional investors include State Street Corp (3.84%), Goldman Sachs Group Inc. (2.58%), Millennium Management LLC (2.24%), JPMorgan Chase & Co. (2.09%), Northern Trust Corp (1.58%) and Loomis Sayles & Co. L P (1.32%). Insiders that own company stock include Brian Farley, Dennis Olis, Elaina Shekhter, Elizabeth Ann Altman, Greg Garrison, Leah Jones, Lisa Khorey, Michael Klayko, Paul Black, Richard J Poulton and Thomas Langan.
View institutional ownership trends.

Shares of MDRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MDRX stock can currently be purchased for approximately $16.67.

Allscripts Healthcare Solutions (NASDAQ:MDRX) has a market capitalization of $1.85 billion and generates $1.50 billion in revenue each year. The software maker earns $134.44 million in net income (profit) each year or $0.43 on an earnings per share basis.

The company employs 8,000 workers across the globe.

Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654. The official website for the company is www.allscripts.com. The software maker can be reached via phone at (800) 334-8534, via email at stephen.shulstein@allscripts.com, or via fax at 313-322-9600.